Source link : https://newshealth.biz/health-news/adjuvant-belzutifan-pembrolizumab-significantly-boosts-dfs-in-kidney-cancer/
(MedPage Today) — SAN FRANCISCO — The adjuvant combination of pembrolizumab (Keytruda) and belzutifan (Welireg) significantly improved disease-free survival (DFS) in patients with clear cell renal cell carcinoma (ccRCC) after nephrectomy versus… Source link : https://www.medpagetoday.com/meetingcoverage/mgucs/120099 Author : Publish date : 2026-02-28 22:17:00 Copyright for syndicated content belongs to the linked Source.
The post Adjuvant Belzutifan-Pembrolizumab Significantly Boosts DFS in Kidney Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2026-02-28 22:17:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8